|
|
Volumn 7, Issue 6 SUPPL., 2012, Pages 100-103
|
|
Autologous cell therapies: The importance of regulatory oversight
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTICLE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
CELL MANIPULATION;
CLINICAL EFFECTIVENESS;
GOOD MANUFACTURING PRACTICE;
GOVERNMENT REGULATION;
HUMAN;
MEDICAL CARE;
PATIENT SAFETY;
PRIORITY JOURNAL;
PUBLIC HEALTH;
QUALITY CONTROL;
REGENERATIVE MEDICINE;
TREATMENT INDICATION;
CLINICAL TRIALS AS TOPIC;
GEOGRAPHY;
GOVERNMENT REGULATION;
HUMANS;
PUBLIC HEALTH;
TISSUE THERAPY;
TRANSPLANTATION, AUTOLOGOUS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84870681717
PISSN: 17460751
EISSN: 1746076X
Source Type: Journal
DOI: 10.2217/rme.12.90 Document Type: Article |
|
Times cited : (10)
|
|
References (1)
|
